MetaCap

Valion Bio Inc. (VBIO)

NASDAQ: VBIOHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

0.4806-0.0593 (-10.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VBIO stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$177.91
52-week range
0.472 – 67.50
Day range
0.48 – 0.5467
Volume / Avg
135.20K / 1.78M
Beta
—

52-week range

$0.472$67.50

VBIO stock today

On Nov 20, VBIO ended the session at $0.4806, shedding $0.0593 (10.98%), versus the S&P 500's 3.70% decline. Trading was light, with 135.20K shares changing hands, about 8% of the average daily volume. At this level, VBIO sits near the bottom of its 52-week range of $0.472 to $67.50: 99.3% below the high and 1.8% above the low.

Valion Bio has posted a net loss over the last twelve months (EPS of -$177.91), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Valion Bio

Company profile

Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. J. Dean Zikria
Headquarters
San Antonio, TX
Employees
52
IPO year
2021

Financial highlights

Full financials

Valion Bio reported a net loss of $8.9 million, compared with a loss of $5.7 million a year earlier.

Valion Bio annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue—$780.00K$1.18M$1.84M$1.26M
Growth—-33.67%-36.09%+46.38%—
Net income$-8.88M$-5.66M$-8.24M$-10.10M$-8.49M
EPS (diluted)—$-19.68$-176.80$-104.32$-2.43

Earnings

Earnings history
Last reported (Sep/2026)
Nov 20, 2026
EPS actual vs est.
$-49.25 vs —

VBIO news

All VBIO news

Valion Bio peers

Health Care sector
VBIO peer companies
CompanyPrice% ChgMarket capCompare
NXLNexalin Technology Inc.1.38-2.13%$1.71Mvs VBIO
NUWENuwellis Inc.3.41-10.50%$1.84Mvs VBIO
NDRAENDRA Life Sciences Inc.3.58-3.38%$5.36Mvs VBIO
IRIXIRIDEX Corporation0.4449-4.59%$7.92Mvs VBIO
ITOCiTonic Holdings Ltd Class A1.59+6.00%$11.63Mvs VBIO
QTIQT Imaging Holdings Inc.1.92+2.67%$28.21Mvs VBIO
ECORelectroCore Inc.4.42-8.87%$40.78Mvs VBIO
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs VBIO

Indexes, lists and sector

Valion Bio stock FAQ

What is Valion Bio's stock price today?

VBIO last traded at $0.4806 as of Nov 20, 4:00 PM EST, down 10.98% on the day. Prices are delayed at least 15 minutes.

Who is Valion Bio's CEO?

Mr. J. Dean Zikria is the chief executive officer of Valion Bio Inc., which has about 52 employees.

What is the VBIO 52-week high?

The 52-week high for VBIO is $67.50 and the 52-week low is $0.472. The stock is currently 99.3% below its high.

Compare VBIO